These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17428692)

  • 1. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans.
    Vairaktaris E; Yannopoulos A; Vassiliou S; Serefoglou Z; Vylliotis A; Nkenke E; Critselis E; Avgoustidis D; Yapijakis C; Neukam FW; Patsouris E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Dec; 104(6):796-802. PubMed ID: 17428692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
    Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
    Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
    Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
    Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
    Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
    Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma.
    Cheng CY; Chang CS; Liu CJ; Kao SY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):79-84. PubMed ID: 18299215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E
    Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Spyridonidou S; Neukam FW; Schlegel KA; Patsouris E
    Anticancer Res; 2008; 28(1A):309-14. PubMed ID: 18383862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.
    Vairaktaris E; Serefoglou ZC; Yapijakis C; Vassiliou S; Nkenke E; Avgoustidis D; Vylliotis A; Stathopoulos P; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4121-5. PubMed ID: 18225582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer.
    Vairaktaris E; Serefoglou Z; Yapijakis C; Stathopoulos P; Vassiliou S; Derka S; Nkenke E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):3981-6. PubMed ID: 18225559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
    Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
    Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
    Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer.
    Vairaktaris E; Serefoglou ZC; Yapijakis C; Agapi C; Vassiliou S; Nkenke E; Antonis V; Sofia S; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4011-4. PubMed ID: 18225563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma.
    Wong YK; Chang KW; Cheng CY; Liu CJ
    J Oral Pathol Med; 2006 Jan; 35(1):51-4. PubMed ID: 16393254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
    Vairaktaris E; Serefoglou Z; Yapijakis C; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(4B):2493-8. PubMed ID: 17695544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas.
    Yang CM; Chen HC; Hou YY; Lee MC; Liou HH; Huang SJ; Yen LM; Eng DM; Hsieh YD; Ger LP
    Arch Oral Biol; 2014 Jan; 59(1):35-46. PubMed ID: 24169152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
    Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW
    J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.